Filing Flows › Bio-Rad Laboratories (BIO) › Q1 2026
Bio-Rad Laboratories (BIO) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 30, 2026
Bio-Rad Laboratories (BIO) reported revenue of $592M for the first quarter 2026 (Q1 2026), +1% from a year earlier and -15% from the quarter before. Operating margin was 5.8%, net loss $527M (89.0% of revenue).
Bio-Rad Laboratories, Q1 2026: revenue $592M (+1% year over year), operating margin 5.8%, net loss $527M, operating cash flow $108M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $592M | -15% | +1% |
| Operating profit | $34.1M | — | +44% |
| Net earnings | −$527M | -173% | -924% |
| Operating cash flow | $108M | -34% | -17% |
| Free cash flow | $78.1M | -34% | -18% |
What changed
Revenue was $592.1M in Q1 2026, up 1% year over year and down 15% from the previous quarter. Clinical Diagnostics was the largest line at 61% of revenue. Clinical Diagnostics added $6.8M year over year (up 2%), 101% of the total change.
Gross margin was 52.3%, unchanged from Q1 2025. Operating profit was $34.1M, a 5.8% margin (up 1.7 points year over year). Of the extra revenue versus Q1 2025, 155% reached operating profit, above the 4% margin then. Operating expenses fell 2% while revenue rose 1%. The quarter ended with a net loss of $527.1M, after a profit of $720.0M the previous quarter. Net interest and other expense of $723.9M was the main reason.
Operating cash flow was $108.1M (down 17% year over year). Non-cash charges added back $15.0M of share-based compensation. Working capital and other items added $620.2M. Capital expenditures of $30.0M left free cash flow of $78.1M.
Questions
What was Bio-Rad Laboratories' revenue in the first quarter 2026?
Bio-Rad Laboratories (BIO) reported revenue of $592M for the first quarter 2026 (Q1 2026), +1% from a year earlier and -15% from the quarter before.
Was Bio-Rad Laboratories profitable in the first quarter 2026?
Operating profit was $34.1M (5.8% of revenue) and net loss $527M.